Diana Naranjo

2.8k total citations
61 papers, 1.9k citations indexed

About

Diana Naranjo is a scholar working on Endocrinology, Diabetes and Metabolism, Genetics and General Health Professions. According to data from OpenAlex, Diana Naranjo has authored 61 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Endocrinology, Diabetes and Metabolism, 14 papers in Genetics and 13 papers in General Health Professions. Recurrent topics in Diana Naranjo's work include Diabetes Management and Research (43 papers), Diabetes Management and Education (20 papers) and Diabetes and associated disorders (14 papers). Diana Naranjo is often cited by papers focused on Diabetes Management and Research (43 papers), Diabetes Management and Education (20 papers) and Diabetes and associated disorders (14 papers). Diana Naranjo collaborates with scholars based in United States, United Kingdom and Australia. Diana Naranjo's co-authors include Korey K. Hood, Molly L. Tanenbaum, Sarah J. Hanes, David M. Maahs, Esti Iturralde, Rachel Bensen, Kellee M. Miller, Danielle Hessler, Lisa A. Strycker and Lawrence Fisher and has published in prestigious journals such as Diabetes Care, Diabetes and Journal of Adolescent Health.

In The Last Decade

Diana Naranjo

54 papers receiving 1.8k citations

Peers

Countries citing papers authored by Diana Naranjo

Since Specialization

Citations

This map shows the geographic impact of Diana Naranjo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Diana Naranjo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Diana Naranjo more than expected).

Fields of papers citing papers by Diana Naranjo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Diana Naranjo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Diana Naranjo. The network helps show where Diana Naranjo may publish in the future.

Co-authorship network of co-authors of Diana Naranjo

This figure shows the co-authorship network connecting the top 25 collaborators of Diana Naranjo. A scholar is included among the top collaborators of Diana Naranjo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Diana Naranjo. Diana Naranjo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Associations Between Socioeconomic Status and Adherence to Medications in People With Cystic Fibrosis 2025 ·Pediatric Pulmonology ·Gabriela R. Oates, Kristin A. Riekert, (unknown), (unknown), Jennifer Butcher, Diana Naranjo, Hanna Phan, Cori Daines, (unknown), Michael S. Schechter, (unknown)	0
2	Stability and impact of diabetes distress over time: The potential value and uses of the type 1 diabetes distress assessment system ( T1 ‐ DDAS ) 2025 ·Diabetic Medicine ·Danielle Hessler, William H. Polonsky, Lisa A. Strycker, Diana Naranjo, (unknown), Lawrence Fisher	0
3	The Experience of Discrimination Impacts Technology Readiness and Psychosocial States of Minoritized Families Living With Type 1 Diabetes: Findings From the BEAD-T1D Pilot Study 2025 ·Endocrine Practice ·Ananta Addala, (unknown), (unknown), Sarah J. Hanes, (unknown), Héctor Ortega, (unknown), Gary M. Shaw, Lisa Chamberlain, Diana Naranjo, Jennifer K. Raymond, David M. Maahs, Korey K. Hood	0
4	Strategies for Equitable Recruitment to Engage Underrepresented Youth and Their Families into Clinical Research: Findings from the BEAD-T1D Pilot Study 2024 ·Hormone Research in Paediatrics ·(unknown), (unknown), Sarah J. Hanes, Gary M. Shaw, Lisa Chamberlain, Jennifer K. Raymond, Diana Naranjo, David M. Maahs, Korey K. Hood, Ananta Addala	4
5	Healthcare Professional Experiences and Opinions on Depression and Suicide in People With Diabetes 2023 ·Journal of Diabetes Science and Technology ·Shideh Majidi, (unknown), Richard I. G. Holt, Mark A. Clements, Simon O’Neill, Éric Renard, (unknown), Diana Naranjo, Laurel H. Messer, David C. Klonoff, Katharine Barnard‐Kelly	1
6	Stakeholders' perspectives on caregiver outcomes for health care transition for adolescents and young adults with special health care needs: A qualitative study 2023 ·Child Care Health and Development ·Cynthia D. Fair, Cecily L. Betz, Diana Naranjo, Jerlym S. Porter, (unknown), (unknown), María Ferris	1
7	Expanding the use of patient-reported outcomes (PROs): Screening youth with type 1 diabetes from underrepresented populations 2023 ·Journal of Diabetes and its Complications ·Ananta Addala, Jessie J. Wong, (unknown), Sarah J. Hanes, (unknown), Rebecca N. Adams, (unknown), Esti Iturralde, Monica S. Lanning, Molly L. Tanenbaum, Diana Naranjo, Korey K. Hood	2
8	DiabetesWise: An innovative approach to promoting diabetes device awareness 2023 ·Journal of Diabetes ·Jessie J. Wong, Ananta Addala, Sarah J. Hanes, (unknown), Diana Naranjo, (unknown), (unknown), Molly L. Tanenbaum, Korey K. Hood	9
9	Psychosocial Effects of the Loop Open-Source Automated Insulin Delivery System 2022 ·Journal of Diabetes Science and Technology ·Jessie J. Wong, Korey K. Hood, Sarah J. Hanes, Rayhan Lal, Diana Naranjo	14
10	Qualitative Study of User Experiences with Loop, an Open-Source Automated Insulin Delivery System 2022 ·Diabetes Technology & Therapeutics ·Sakinah C. Suttiratana, Jessie J. Wong, Monica S. Lanning, (unknown), Sarah J. Hanes, Korey K. Hood, Rayhan Lal, Diana Naranjo	10
11	Cost considerations for adoption of diabetes technology are pervasive: A qualitative study of persons living with type 1 diabetes and their families 2021 ·Diabetic Medicine ·Ananta Addala, Sakinah C. Suttiratana, Jessie J. Wong, Monica S. Lanning, Katharine Barnard, Jill Weissberg‐Benchell, Lori M. Laffel, Korey K. Hood, Diana Naranjo	25
12	Discontinued Use of the Loop Insulin Dosing System: A Mixed-Methods Investigation 2021 ·Diabetes Technology & Therapeutics ·Jessie J. Wong, Sakinah C. Suttiratana, Rayhan Lal, John W. Lum, Monica S. Lanning, (unknown), (unknown), Sarah J. Hanes, Ryan Bailey, Korey K. Hood, Diana Naranjo	11
13	An Intolerable Burden: Suicide, Intended Self-Injury and Diabetes 2020 ·Canadian Journal of Diabetes ·Katharine Barnard‐Kelly, Diana Naranjo, Shideh Majidi, Halis Kaan Aktürk, Marc D. Breton, Philippe Courtet, Émilie Olié, Rayhan Lal, Nicole L. Johnson, Mark A. Atkinson, Éric Renard	5
14	A Real-World Prospective Study of the Safety and Effectiveness of the Loop Open Source Automated Insulin Delivery System 2020 ·Diabetes Technology & Therapeutics ·John W. Lum, Ryan Bailey, (unknown), Diana Naranjo, Korey K. Hood, Rayhan Lal, (unknown), Adam S. Brown, Daniel J. DeSalvo, Jeremy Pettus, Peter Calhoun, Roy W. Beck	96
15	Parental Perspectives: Identifying Profiles of Parental Attitudes and Barriers Related to Diabetes Device Use 2020 ·Diabetes Technology & Therapeutics ·Jessie J. Wong, (unknown), Sarah J. Hanes, Molly L. Tanenbaum, Monica S. Lanning, Diana Naranjo, Korey K. Hood	11
16	You, me, and diabetes: Intimacy and technology among adults with T1D and their partners. 2020 ·Families Systems & Health ·(unknown), Lindsey E. G. Weil, Lindsay M. Anderson, Diana Naranjo, Katharine Barnard‐Kelly, Lori M. Laffel, Korey K. Hood, Jill Weissberg‐Benchell	8
17	Assessing patient‐reported outcomes for automated insulin delivery systems: the psychometric properties of the INSPIRE measures 2019 ·Diabetic Medicine ·Jill Weissberg‐Benchell, Jenna B. Shapiro, Korey K. Hood, Lori M. Laffel, Diana Naranjo, Kellee M. Miller, Katharine Barnard	66
18	Psychosocial and Human Factors During a Trial of a Hybrid Closed Loop System for Type 1 Diabetes Management 2018 ·Diabetes Technology & Therapeutics ·Rebecca N. Adams, Molly L. Tanenbaum, Sarah J. Hanes, Jodie M. Ambrosino, Trang T. Ly, David M. Maahs, Diana Naranjo, Natalie Walders‐Abramson, Stuart A. Weinzimer, Bruce A. Buckingham, Korey K. Hood	26
19	Implementation of Depression Screening and Global Health Assessment in Pediatric Subspecialty Clinics 2017 ·Journal of Adolescent Health ·Esti Iturralde, Rebecca N. Adams, (unknown), Rachel Bensen, (unknown), Sarah J. Hanes, David M. Maahs, Carlos Milla, Diana Naranjo, Avni Shah, Molly L. Tanenbaum, (unknown), K.T. Park, Korey K. Hood	47
20	International and Interdisciplinary Identification of Health Care Transition Outcomes 2015 ·JAMA Pediatrics ·Cynthia D. Fair, (unknown), Niraj Sharma, Gary Maslow, Lori Wiener, Cecily L. Betz, Jerlym S. Porter, Suzanne McLaughlin, Jordan Gilleland Marchak, (unknown), Diana Naranjo, Sophie Jan, Karina Javalkar, María Ferris	132

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact